29 June 2021
  • Share

Jim Mellon, investor in innovation, entrepreneur and author, joins us for our new podcast. With insights from Jim's latest book, Moo's Law: An investor's guide to the new agrarian revolution, this episode tackles the subject of cellular agriculture. Caitlin Mackesy Davies, editor of Mewburn Ellis Forward, speaks to Jim about the new technologies and ventures that are taking on the challenge of providing alternatives to current agriculture, particularly animal farming. 

Listen time: 27 minutes 

Jim Mellon Podcast v2

 

Episode guide 

  • Episode intro (00:18)
  • Factors making this the right time for alternative proteins to take centre stage (00:30)
  • Framing the discussion around Moo's Law (02:48)
  • Key technologies behind cellular agriculture (04:44)
  • Notable companies in the cellular agriculture space (08:42)
  • Breadth and width of the agrarian revolution (12:01)
  • Five key areas for investment (12:51)
  • The role of IP (15:54)
  • Animal welfare (17:35)
  • Changes needed for the agrarian revolution to take place (19:25)
  • Innovators and investors helping meet the challenges (22:46)
  • Next areas to champion (24:23)

Useful links

Jim Mellon's latest book - Moo's Law: An investor's guide to the new agrarian revolution

Learn more about how Jim has been taking on ageing with investment in the longevity tech space

Compelling advancements in cellular science could soon see us choosing to abandon animal agriculture. Forward explores the emerging world of cultured meat - is the future of meat animal-free?

Visit our future food spotlight page for more information on the topic and view our blog series


More about Mewburn Ellis Forward

Forward celebrates the most compelling developments taking place in the scientific and entrepreneurial worlds and covers the IP challenges that international organisations face every day. This podcast is part of our new Forward: On Demand series - video blogs (vlogs), podcasts and webinars available to watch or listen to at any time. View the full series here and the podcast series here

Sign up to our monthly Forward newsletter to receive the latest news, insights, features and on demand content direct to your inbox each month. 

Adam is a Partner and Patent Attorney at Mewburn Ellis. He works with biotech companies to build and manage their patent portfolios, drafting patent applications and co-ordinating prosecution worldwide. Adam has particular experience handling portfolios relating to therapeutics (particularly immunotherapies, including adoptive cellular therapies), antibody technology, diagnostics, and regenerative medicine.
Comments

Sign up to our newsletter: Forward - news, insights and feature

Our People

Our IP specialists work at all stage of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.

OUR PEOPLE

Contact Us

We have an easily-accessible office in central London, as well as a number of regional offices throughout the UK and an office in Munich, Germany.  We’d love to hear from you, so please get in touch.